Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...
Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...
YouTube on MSN
Building LEGO weapon models for display
This video shows how to build non functional LEGO weapon models intended for display or prop use only. The tutorial explains ...
Concerns are rising that the US may no longer come to Europe's defence, which could force European countries - including the UK - to increase their military spending. Since the Russian full-scale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback